Weight loss results are consistent among users who stay on the program
Rybelsus (Pills): You start with 3 mg once a day for a month
Their effects are marked by increased satiety, reduced appetite, and improved metabolic biomarkers, with a safety profile dominated by mild to moderate gastrointestinal adverse events
Abbasinejad evaluates every patient personally, but generally, the ideal candidate falls into one of the following categories: BMI Criteria: Adults with a Body Mass Index (BMI) of 30 or higher (obesity), or a BMI of 27 or higher (overweight) who also have at least one weight-related medical condition, such as hypertension, high cholesterol , or type 2 diabetes
While major weight loss isnt typically seen in this phase, many patients report reduced appetite, fewer cravings, and more control over portion sizesall strong indicators that the medication is working